-
Australia's new Ghost Shark submarines grow some 'teeth'
-
China's third-quarter growth narrowly beats forecasts
-
'I call it a bribe': Pennsylvania residents spurn $10,000 data center checks
-
Asian stocks start week on back foot, tracking tech-led Wall St losses
-
In a former US steel city, ordinary people struggle to get by
-
China growth narrowly beats forecasts
-
'Liar,' 'clown': Lula and Bolsonaro spar in Brazil poll debate
-
Faith and fury: Texas Senate rivals offer contrasting visions
-
Record El Nino? Depends who's counting
-
Women await justice for police killings in Brazil
-
On the front line of ocean conservation off Portugal's Madeira
-
The painstaking task of cataloguing the world's species
-
Wembanyama targets title breakthrough as NBA season tips off
-
Nations seek reset at UN talks as nature goals off track
-
With LeBron on board it's title or bust for Philly fans
-
Rubio seeks to strengthen US foothold in Central Asia
-
One year after Louvre heist, where are the missing jewels?
-
LeBron joins 76ers to chase one more NBA title at age 41
-
Knicks face tall task in NBA championship repeat bid
-
Rays one win from World Series return after downing Guardians
-
Warriors' Curry 'fine' after limping out of practice - Kerr
-
BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 19
-
Caledonia Mining Corporation Plc: Notification of Relevant Change To Significant Shareholder
-
Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement
-
Kings' Ben Simmons tears Achilles in training
-
Zelensky speaks to US envoys as Trump lashes out
-
Lula, Bolsonaro set for first debate showdown in bitter election race
-
'Surprise package' Lazio crush Juve to keep pace with Serie A leaders Inter
-
Mbappe hits two as Real Madrid rout Sevilla
-
China growth expected to miss official target in third quarter
-
Browns edge Ravens for division lead, Texans beat Jags
-
Lazio crush Juventus to move level with Serie A leaders Inter
-
Lyon go top of Ligue 1 as Monaco fall to first defeat of the season
-
Leeds draw feels like 'fresh start' for Man Utd's Carrick
-
Venezuela opposition alliance reaffirms Nobel laureate Machado as leader
-
Macron denounces 'unbridled' violence as France hit by new clashes
-
'Street Fighter' wins N. America box office, buzzy doc stuns in 2nd
-
Hurzeler lauds 'hard worker' Gomez after Brighton goal from halfway line
-
NFL: Paris game to go ahead despite protests in France
-
Toulouse hold off Exeter, Northampton save English Champions Cup blushes
-
Arteta hails Arsenal 'finishers' after Madueke fells Forest
-
Arsenal snatch late win to keep pressure on Man City as Man Utd held
-
Trump backs ally Netanyahu ahead of Israel's tight election
-
Arsenal strike late to keep pressure on Man City as Man Utd held
-
Madueke strikes late as below-par Arsenal sink Forest
-
Four soldiers dead, dozens injured in fire at Canada military base
-
Second day of street clashes in Milan
-
Ton-up Agha helps Pakistan down Sri Lanka in tri-series opener
-
Dupont's Toulouse hold off Exeter as English Champions Cup woes continue
Teknova Expands Digital Publication Experience with Bioz Content Hub Integration
PALO ALTO, CA / ACCESS Newswire / June 16, 2026 / Bioz, Inc., an innovative platform focused on extracting and syndicating insights from scientific publications, announced its continued collaboration with Teknova, a leading manufacturer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Building on a long-standing collaboration, Teknova has expanded its use of Bioz Badges by implementing a fully customized Bioz Content Hub, creating a centralized, standalone destination for publication data across its product portfolio.
As the volume of scientific literature continues to grow, suppliers face increasing challenges in organizing and presenting validated evidence in a way that is both scalable and user-friendly. Teknova's Content Hub addresses this by consolidating peer-reviewed publications into a dedicated, searchable environment, enabling researchers to easily explore how Teknova's customers use the company's products across a wide range of applications.
"Long-term "collaborators" or "users" like Teknova understand the importance of not only surfacing publication data, but doing so in a way that aligns with their digital strategy and user experience," said Dr. Karin Lachmi, Co-Founder and Chief Revenue Officer at Bioz. "By expanding from Bioz Badges to a fully customized Content Hub, Teknova has created a highly intuitive and scalable solution that strengthens scientific transparency while enhancing engagement."
The Teknova Content Hub is fully tailored to match the look, feel, and navigation of their website, ensuring a seamless user experience. Rather than directing users to external or static resources, the Bioz Content Hub integrates directly within Teknova's digital ecosystem, allowing researchers to browse, filter, and interact with publication data in a way that feels native to the site. Users can easily navigate from publications to associated product webpages, creating a streamlined path from evaluation to procurement.
"The nature of our work with Bioz has evolved alongside our digital strategy," said Christa Plon, Marketing Operations Specialist at Teknova. "The launch of our Bioz Content Hub allows us to present publication data in a way that is not only comprehensive, but also highly aligned with our brand and user experience. The level of UI customization ensures that researchers can engage with our content intuitively while exploring real-world applications of our products."
Jennifer Henry, Senior Vice President of Marketing at Teknova, added, "Having a centralized publication resource has significantly improved how we organize and present scientific validation across our vast product portfolio. The ability to seamlessly connect publications to each individual product makes it easier for customers to find relevant data and better understand the practical and real-world usage of our products in the development of next-generation therapeutics and diagnostics.."
In adding a standalone Bioz Content Hub, Teknova is reinforcing its commitment to evidence-driven communication, user-centric design, and scalable digital infrastructure. The integration eliminates the need for manual publication tracking while ensuring that citation data remains continuously updated, accessible, and actionable for researchers.
About Bioz
Bioz is the world's most advanced citation platform for scientific research, offering evidence-based product ratings and recommendations to guide scientists toward the most validated products for their discoveries. Bioz's solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. Teknova offers fully customizable solutions for every stage of the workflow, supporting industry leaders in genomics, molecular diagnostics, and emerging therapeutic modalities. Their fast turnaround of high-quality agar plates, microbial culture and cryopreservation media, buffers and reagents, and water helps customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova's modular manufacturing platform was designed by their team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Helpful Links
For more information about Bioz solutions for suppliers, please reach out to [email protected].
SOURCE: Bioz, Inc.
View the original press release on ACCESS Newswire
O.Johnson--AMWN